Synthesis of novel benzbromarone derivatives designed to avoid metabolic activation

Tomoyuki Ohe; Ryutaro Umezawa; Yumina Kitagawara; Daisuke Yasuda; Kyoko Takahashi; Shigeo Nakamura; Akiko Abe; Shuichi Sekine; Kousei Ito; Kentaro Okunushi; Hanae Morio; Tomomi Furihata; Naohiko Anzai; Tadahiko Mashino

doi:10.1016/j.bmcl.2018.10.023

Synthesis of novel benzbromarone derivatives designed to avoid metabolic activation

Tomoyuki Ohe, Ryutaro Umezawa, Yumina Kitagawara, Daisuke Yasuda, Kyoko Takahashi, Shigeo Nakamura, Akiko Abe, Shuichi Sekine, Kousei Ito, Kentaro Okunushi, Hanae Morio, Tomomi Furihata, Naohiko Anzai, Tadahiko Mashino

School of Pharmaceutical Sciences

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

We synthesized six novel BBR derivatives that were designed to avoid metabolic activation via ipso-substitution and evaluated for their degree of toxicity and hURAT1 inhibition. It was found that all of the derivatives demonstrate lower cytotoxicity in mouse hepatocytes and lower levels of metabolic activation than BBR, while maintaining their inhibitory activity toward the uric acid transporter. We propose that these derivatives could serve as effective uricosuric agents that have much better safety profiles than BBR.

Original language	English
Journal	Bioorganic and Medicinal Chemistry Letters
DOIs	https://doi.org/10.1016/j.bmcl.2018.10.023
Publication status	Accepted/In press - 2018 Jan 1

Keywords

Benzbromarone
Hepatotoxicity
Metabolic activation
URAT1

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

Access to Document

10.1016/j.bmcl.2018.10.023

Fingerprint Dive into the research topics of 'Synthesis of novel benzbromarone derivatives designed to avoid metabolic activation'. Together they form a unique fingerprint.

Cite this

Synthesis of novel benzbromarone derivatives designed to avoid metabolic activation. / Ohe, Tomoyuki; Umezawa, Ryutaro; Kitagawara, Yumina; Yasuda, Daisuke; Takahashi, Kyoko; Nakamura, Shigeo; Abe, Akiko; Sekine, Shuichi; Ito, Kousei; Okunushi, Kentaro; Morio, Hanae; Furihata, Tomomi; Anzai, Naohiko; Mashino, Tadahiko.

In: Bioorganic and Medicinal Chemistry Letters, 01.01.2018.

Research output: Contribution to journal › Article › peer-review

Ohe, Tomoyuki ; Umezawa, Ryutaro ; Kitagawara, Yumina ; Yasuda, Daisuke ; Takahashi, Kyoko ; Nakamura, Shigeo ; Abe, Akiko ; Sekine, Shuichi ; Ito, Kousei ; Okunushi, Kentaro ; Morio, Hanae ; Furihata, Tomomi ; Anzai, Naohiko ; Mashino, Tadahiko. / Synthesis of novel benzbromarone derivatives designed to avoid metabolic activation. In: Bioorganic and Medicinal Chemistry Letters. 2018.

@article{a2105a77b1cb45a7a13d086f5aaaf72e,

title = "Synthesis of novel benzbromarone derivatives designed to avoid metabolic activation",

abstract = "We synthesized six novel BBR derivatives that were designed to avoid metabolic activation via ipso-substitution and evaluated for their degree of toxicity and hURAT1 inhibition. It was found that all of the derivatives demonstrate lower cytotoxicity in mouse hepatocytes and lower levels of metabolic activation than BBR, while maintaining their inhibitory activity toward the uric acid transporter. We propose that these derivatives could serve as effective uricosuric agents that have much better safety profiles than BBR.",

keywords = "Benzbromarone, Hepatotoxicity, Metabolic activation, URAT1",

author = "Tomoyuki Ohe and Ryutaro Umezawa and Yumina Kitagawara and Daisuke Yasuda and Kyoko Takahashi and Shigeo Nakamura and Akiko Abe and Shuichi Sekine and Kousei Ito and Kentaro Okunushi and Hanae Morio and Tomomi Furihata and Naohiko Anzai and Tadahiko Mashino",

year = "2018",

month = jan,

day = "1",

doi = "10.1016/j.bmcl.2018.10.023",

language = "English",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Synthesis of novel benzbromarone derivatives designed to avoid metabolic activation

AU - Ohe, Tomoyuki

AU - Umezawa, Ryutaro

AU - Kitagawara, Yumina

AU - Yasuda, Daisuke

AU - Takahashi, Kyoko

AU - Nakamura, Shigeo

AU - Abe, Akiko

AU - Sekine, Shuichi

AU - Ito, Kousei

AU - Okunushi, Kentaro

AU - Morio, Hanae

AU - Furihata, Tomomi

AU - Anzai, Naohiko

AU - Mashino, Tadahiko

PY - 2018/1/1

Y1 - 2018/1/1

N2 - We synthesized six novel BBR derivatives that were designed to avoid metabolic activation via ipso-substitution and evaluated for their degree of toxicity and hURAT1 inhibition. It was found that all of the derivatives demonstrate lower cytotoxicity in mouse hepatocytes and lower levels of metabolic activation than BBR, while maintaining their inhibitory activity toward the uric acid transporter. We propose that these derivatives could serve as effective uricosuric agents that have much better safety profiles than BBR.

AB - We synthesized six novel BBR derivatives that were designed to avoid metabolic activation via ipso-substitution and evaluated for their degree of toxicity and hURAT1 inhibition. It was found that all of the derivatives demonstrate lower cytotoxicity in mouse hepatocytes and lower levels of metabolic activation than BBR, while maintaining their inhibitory activity toward the uric acid transporter. We propose that these derivatives could serve as effective uricosuric agents that have much better safety profiles than BBR.

KW - Benzbromarone

KW - Hepatotoxicity

KW - Metabolic activation

KW - URAT1

UR - http://www.scopus.com/inward/record.url?scp=85055697971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055697971&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2018.10.023

DO - 10.1016/j.bmcl.2018.10.023

M3 - Article

C2 - 30389287

AN - SCOPUS:85055697971

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

ER -